Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators?

Journal of Cardiovascular Electrophysiology

Volumn 11, Issue 2, 2000, Pages 127-135

  Glikson, Michael ^b,c   Luria, David ^a   Friedman, Paul A ^a   Trusty, Jane M ^a   Benderly, Michal ^b   Hammill, Stephen C ^a   Stanton, Marshall S ^a  

^a MAYO CLINIC   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Follow up; Implantable cardioverter defibrillator

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0033977027     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2000.tb00311.x     Document Type: Article

References (24)

1. 1. Lehmann MH, Saksena S: Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology. PACE 1991; 14:969-979.
2. 2. Friedman PA, Stanton MS: The pacer-cardioverter-defibrillator: Function and clinical experience. J Cardiovasc Electrophysiol 1995;6:48-68.
3. 3. Minten J, Cuypers A, van Binsbergen E, et al: Medtronic Model 7219 Jewel® PCD® European Clinical Report. Medtronic Bakken Research Center, Maastricht, 1995.
4. 4. Block M, and the European P2 investigators: Combination of endocardial leads with new ICD capable of biphasic shocks: First results of a multicenter study. PACE 1993;16:874A.
5. 5. Bardy GH, Yee R, Jung W, et al: Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. J Am Coll Cardiol 1996;28:400-410.
6. 6. Giri S, Berns E, Edwards AC, et al: Post implant cardioverter defibrillator programming: Is predismissal electrophysiologic testing necessary? (Abstract) PACE 1996;19:678.
7. 7. Connely DT, Cardinal D, Foley L, et al: Is routine pre discharge testing necessary for patients with implantable cardioverter defibrillator? (Abstract) PACE 1996;19:614.
8. 8. Wieckhorst A, Buchwald A, Unterberg C: On the necessity of the invasive predischarge test after implantation of a cardioverter defibrillator. Am J Cardiol 1998;81:933-935.
9. 9. Schaumann A, von zur Muhlen F, Herse B, et al: Empirical versus tested antitachycardia pacing in Implantable Cardioverter Defibrillators: A prospective study including 200 patients. Circulation 1998; 97:66-74.
10. 10. SAS Institute, Inc.: SAS Procedure Guide, Version 6. Third Edition. SAS Institute Inc., Cary, NC, 1990, p. 705; SAS/STAT®Software: Changes and Enhancements Through Release 6.11. SASInstitute Inc., Cary, NC, 1996, p. 1104.
11. 10. SAS Institute, Inc.: SAS Procedure Guide, Version 6. Third Edition. SAS Institute Inc., Cary, NC, 1990, p. 705; SAS/STAT® Software: Changes and Enhancements Through Release 6.11. SAS Institute Inc., Cary, NC, 1996, p. 1104.
12. 11. Church T, Martinson M, Kallok M, et al: A model to evaluate alternative methods of defibrillation threshold determination. PACE 1988;11:2002-2007.
13. 12. Glikson M, Trusty JM, Grice SK, et al: A stepwise testing protocol for modern implantable cardioverter defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions. Am J Cardiol 1999;83:360-366.
14. 13. Brunn J, Block M, Weber M, et al: Routinely performed tests of the defibrillation function of ICDs are not mandatory. (Abstract) PACE 1996; 19:605.
15. 14. Halperin BD, Lyons H, Kron J, et al: Post operative efficacy of transvenous defibrillation: To test or not to test. (Abstract) PACE 1997;20:1225.
16. 15. Le Feuvre C, Klein GJ, Sakun V, et al: Is predismissal ICD defibrillation threshold testing necessary? (Abstract) PACE 1995; 18:827.
17. 16. Higgins SL, Rich DH, Haygood JR, et al: ICD restudy: Results and potential benefit from routine predischarge and 2-month evaluation. PACE 1998;21:410-417.
18. 17. Goldberger JJ, Horvath G, Inbar S, et al: Utility of predischarge and one month transvenous implantable defibrillator tests. Am J Cardiol 1997;79:823-826.
19. 18. Geiger MJ, O'Neill P, Sharma A, et al: Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. PACE 1997;20: 624-630.
20. 19. Gillis AM, Sheldon RS, Wyse DG, et al: Long term reproducibility of ventricular tachycardia induction on patients with implantable cardioverter defibrillators: Serial noninvasive testing. Circulation 1995;91:2605-2613.
21. 20. Brady P, Friedman PA, Trusty JM, et al: High failure rate for a chronic epicardial implantable cardioverter defibrillator lead. J Am Coll Cardiol 1998;31:616-622.
22. 21. Luria D, Rasmussen MJ, Hammill SC, et al: Frequency and mode of detection of nonthoracotomy implantable defibrillator lead failure. (Abstract) PACE 1999;22:705.
23. 22. Korte T, Jung W, Spehl S, et al: Incidence of ICD lead complications during long term follow-up: Comparison of epicardial and endocardial electrode systems. PACE 1995;18:2053-2061.
24. 23. Muller D, Hoffman E, Dorwarth U, et al: Failures of transvenous leads for implantable cardioverter defibrillators during long term follow-up. (Abstract) PACE 1997;20:1225.